Skip To Main Content

Artikkelit

Järjestä

Suodattimet

Nollaa
  • Terapia-alue

Beyfortus® ▼(nirsevimab): effectiveness and public health impact in the real world

Gaucher disease in children

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.

Real-World Evidence and Phase IV studies in CRSwNP

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.

DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

EFLUELDA - korkea-annoksinen influenssarokote

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care

Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.